+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dienogest"

Dienogest (CAS 65928-58-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Thumbnail Image

Dienogest (CAS 65928-58-7) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • October 2026
  • 50 Pages
  • Global
From
Dienogest API Market - Global Forecast 2026-2032 - Product Thumbnail Image

Dienogest API Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 184 Pages
  • Global
From
Endometriosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Endometriosis Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • August 2026
  • 110 Pages
  • Global
From
The Hormonal Treatment of Endometriosis and Adenomyosis. A Comprehensive Review of the Role of Hormonal Treatments in the Management of Pain and Infertility in Patients with Endometriosis and Adenomyosis - Product Thumbnail Image

The Hormonal Treatment of Endometriosis and Adenomyosis. A Comprehensive Review of the Role of Hormonal Treatments in the Management of Pain and Infertility in Patients with Endometriosis and Adenomyosis

  • Book
  • October 2026
  • 4 Results (Page 1 of 1)
Loading Indicator

Dienogest is a synthetic progestin used in the treatment of endometriosis and other gynecological disorders. It is a member of the 19-nortestosterone family of progestins and is used in combination with estrogens in oral contraceptives. Dienogest is also used in the treatment of heavy menstrual bleeding and as a hormone replacement therapy for menopausal symptoms. Dienogest is a key player in the Sexual and Reproductive Health Drugs market, providing a safe and effective treatment for a range of gynecological disorders. It is used in combination with estrogens in oral contraceptives, providing a reliable form of contraception. It is also used in the treatment of heavy menstrual bleeding and as a hormone replacement therapy for menopausal symptoms. Companies in the Dienogest market include Bayer AG, Merck KGaA, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Mylan N.V. Show Less Read more